Stay updated on Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial
Sign up to get notified when there's something new on the Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial page.

Latest updates to the Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page’s revision tag updated from Revision: v3.6.4 to Revision: v3.6.5, signaling a minor system update. This change does not affect the study data or history content displayed on the page.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedRevision 3.6.4 was issued, adding new sections such as Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, Document Section, References, and Study Status, and the record was returned on 2026-07-23. The update also shows that the Quality Control Review Has Not Concluded and that the previous revision 3.6.3 was removed.SummaryDifference0.8%

- Check53 days agoChange DetectedA new 'Results Submitted' addition is shown and the latest revision is 'Revision: v3.6.3'. The entries 'No Results Posted' and 'Revision: v3.6.2' have been removed.SummaryDifference0.1%

- Check60 days agoChange DetectedAdded a new revision entry Revision: v3.6.2 to the study record history and removed the prior Revision: v3.6.0. This is a minor metadata update to the page’s version history and does not change trial details.SummaryDifference0.1%

- Check75 days agoChange DetectedAdded a note stating 'No longer looking for participants' to reflect the recruitment status. Updated the revision tag to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.2%

- Check82 days agoChange DetectedThe record history now includes a new revision label, Revision: v3.5.5, indicating a recent UI/system update; the previous Revision: v3.5.4 entry was removed from the history list.SummaryDifference0.1%

Stay in the know with updates to Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Capivasertib+Abiraterone in PTEN-deficient Prostate Clinical Trial page.